LATEX CONDOMS COLOUR WITH SPERMICIDAL LUBRICANT

K974324 · Reddy Medtech Health Products , Ltd. · LTZ · Feb 9, 1998 · Obstetrics/Gynecology

Device Facts

Record IDK974324
Device NameLATEX CONDOMS COLOUR WITH SPERMICIDAL LUBRICANT
ApplicantReddy Medtech Health Products , Ltd.
Product CodeLTZ · Obstetrics/Gynecology
Decision DateFeb 9, 1998
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 884.5310
Device ClassClass 2
AttributesTherapeutic

Intended Use

If used properly, condoms will help to reduce the risk of transmission of HIV infection (AIDS) and many other sexually transmitted diseases, including chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B and syphilis. Condoms, when properly used, are highly effective against pregnancy although no contraceptive can guarantee 100% effectiveness. Any use of this condom for other than vaginal intercourse can increase the potential damage to the condom. For maximum pleasure and protection, it is important to follow the instructions for use included inside this package. Failure to do so may result in the loss of the benefits of the condom.

Device Story

Latex condom with spermicidal lubricant; intended for over-the-counter use during vaginal intercourse. Acts as physical barrier to prevent pregnancy and reduce transmission of sexually transmitted diseases. Spermicidal lubricant provides additional protection. User-operated; requires proper application per instructions to maintain integrity and effectiveness. Non-vaginal use increases risk of condom damage.

Clinical Evidence

No clinical data provided; substantial equivalence based on regulatory classification and adherence to established manufacturing standards for latex condoms.

Technological Characteristics

Latex material; spermicidal lubricant; physical barrier design. Regulated under 21 CFR 884.5310 (Procode: 85 LTZ & HIS).

Indications for Use

Indicated for use by individuals during vaginal intercourse to prevent pregnancy and reduce the risk of transmission of HIV (AIDS) and other sexually transmitted diseases (chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, syphilis).

Regulatory Classification

Identification

A condom with spermicidal lubricant is a sheath which completely covers the penis with a closely fitting membrane with a lubricant that contains a spermicidal agent, nonoxynol-9. This condom is used for contraceptive and prophylactic purposes (preventing transmission of venereal disease).

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows a logo for the Department of Health. The logo features a stylized human figure with three curved lines representing the head, body, and legs. The figure is positioned to the right of the text "DEPARTMENT OF HEALTH" which is arranged vertically. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Ravi Reddy Reddy Medtech Health Products, Ltd. 9 Webster Court Plainsboro, NJ 08536 Re: K974324 Latex Condoms, with Spermicidal Lubricant Dated: November 7, 1997 Received: November 18, 1997 Regulatory Class: II 21 CFR 884.5310/Procode: 85 LTZ & HIS FEB - 9 1998 Dear Mr. Reddy: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitto diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (30) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, h. William Griffin Lillian Yin, Ph.D. Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {1}------------------------------------------------ 11 Page 1 of -- 510(k) NUMBER (IF KNOWN): K 97432 DEVICE NAME: INDICATIONS FOR USE: If used properly, condoms will help to reduce the risk of transmission of HIV infection (AIDS) and many other sexually transmitted diseases, including chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B and syphilis. Condoms, when properly used, are highly effective against pregnancy although no contraceptive can guarantee 100% effectiveness. Any use of this condom for other than vaginal intercourse can increase the potential damage to the condom. For maximum pleasure and protection, it is important to follow the instructions for use included inside this package. Failure to do so may result in the loss of the benefits of the condom. (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED.) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use (Per 21 CFR 801.109) OR Over-The-Counter-Use (Optional Format 1-2-96) Robert D. Rathbun/ (Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological Devices K974324 510(k) Number
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...